| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |